Gary Patou
Director · 2 filings · Latest: Jun 5, 2026
Xenon Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XENE | Gary Patou | Director | Jun 5, 2026 | Sale | $53.14 | 1,322 | $70.3K | 24,896 | |
XENE | GARY PATOU | — | Jun 5, 2026 | Proposed Sale | $52.99 | 1,322 | $70.1K | — | |
XENE | Gary Patou | Director | Jun 1, 2026 | Option Exercise | — | 2,645 | — | 26,218 | |
XENE | GARY PATOU | — | Nov 22, 2024 | Proposed Sale | $41.08 | 4,891 | $200.9K | — |